Compared with the traditional medical reference values, they showed higher accuracy despite the established evidence for B-cell, CEA, and CA153 for assessing the risk of recurrence and prognosis in breast cancer patients (Coronella-Wood and Hersh, 2003; Dai et al., 2016). Here, CEACAM5 is linked to breast carcinoma.